Pharmaceuticals Insider Trading
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
Activity
About industry performance (blue line)
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.
Recent Transactions
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | ORGO Organogenesis Holdings Inc. | Gillheeney Gary S.73 | President And CEO | Sell | 259,332 | $3.62 | $940,066.17 | -2.6% | +49.0% | +36.5% | |
| Dec 11, 2024 | ANIP Ani Pharmaceuticals Inc | Davis Krista45 | SVP, Chief Hr Officer | Sell | 1,000 | $60.00 | $60,000.00 | -2.0% | +3.8% | +38.8% | |
| Dec 11, 2024 | AVDL Avadel Pharmaceuticals Plc | McHugh Thomas S73 | Chief Financial Officer | Buy | 5,000 | $10.49 | $52,432.50 | +6.2% | -22.5% | +107.3% | |
| Dec 11, 2024 | TCNNF Trulieve Cannabis Corp. | Getman Wes | Chief Financial Officer | Buy | 9,500 | $4.91 | $46,645.00 | +25.3% | - | - | |
| Dec 10, 2024 | AVDL Avadel Pharmaceuticals Plc | Glass Geoffrey Michael70 | Director | Buy | 20,279 | $9.84 | $199,640.95 | +16.3% | -23.9% | +114.8% | |
| Dec 10, 2024 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 85,561 | $31.01 | $2,653,128.90 | -4.2% | +11.7% | +22.7% | |
| Dec 10, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 7,259 | $32.25 | $234,102.75 | -3.8% | +11.7% | +22.7% | |
| Dec 9, 2024 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 10,000 | $367.69 | $3,676,877.00 | -31.3% | -13.4% | +29.8% | |
| Dec 9, 2024 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 10,000 | $43.77 | $437,702.00 | -24.7% | -35.2% | -41.5% | |
| Dec 9, 2024 | PRGO Perrigo Co Plc | Kindler Jeffrey B71 | Director | Sell | 17,598 | $28.27 | $497,495.46 | -76.5% | -1.8% | -52.3% | |
| Dec 9, 2024 | ALKS Alkermes Plc. | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 61,151 | $32.07 | $1,961,406.09 | -56.2% | +12.6% | -9.2% | |
| Dec 9, 2024 | ALKS Alkermes Plc. | Laurencin Cato T59 | Director | Sell | 2,691 | $31.85 | $85,708.35 | -10.5% | +12.6% | -9.2% | |
| Dec 9, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Ragosa Mark | Chief Financial Officer | Sell | 27,829 | $21.34 | $593,997.43 | -37.7% | -2.2% | +93.0% | |
| Dec 9, 2024 | AVDL Avadel Pharmaceuticals Plc | Divis Gregory J71 | Chief Executive Officer | Buy | 10,000 | $9.97 | $99,706.89 | +104.2% | -25.0% | +110.0% | |
| Dec 9, 2024 | ORGO Organogenesis Holdings Inc. | Gillheeney Gary S.73 | President And CEO | Sell | 59,468 | $3.56 | $211,721.44 | -0.9% | +46.6% | +32.9% | |
| Dec 6, 2024 | AVDL Avadel Pharmaceuticals Plc | Palczuk Linda78 | Director | Buy | 3,000 | $10.19 | $30,567.60 | +4.7% | -21.2% | +113.4% | |
| Dec 5, 2024 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 7,700 | $374.37 | $2,882,649.00 | -17.3% | -16.9% | +30.7% | |
| Dec 5, 2024 | ALKS Alkermes Plc. | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 9,221 | $31.50 | $290,461.50 | -13.4% | +13.1% | -5.4% | |
| Dec 5, 2024 | TLPH Talphera, Inc. | Angotti Vincent J.56 | Chief Executive Officer | Buy | 5,000 | $0.64 | $3,199.50 | +2.5% | -20.3% | +79.8% | |
| Dec 5, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Ragosa Mark | Chief Financial Officer | Sell | 15,116 | $21.37 | $323,008.80 | -18.0% | +2.0% | +98.6% | |
| Dec 4, 2024 | ALKS Alkermes Plc. | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 14,349 | $30.77 | $441,550.30 | -17.2% | +14.0% | -5.7% | |
| Dec 4, 2024 | VRNO Verano Holdings Corp. | Spreckman David | Chief Marketing Officer | Sell | 5,470 | $1.37 | $7,515.97 | -2.3% | - | - | |
| Dec 4, 2024 | VRNO Verano Holdings Corp. | Summerer Brett Andrew | Chief Financial Officer | Sell | 9,724 | $1.37 | $13,324.55 | -4.9% | - | - | |
| Dec 4, 2024 | VRNO Verano Holdings Corp. | Weiss Darren Henry | President | Sell | 20,147 | $1.37 | $27,652.50 | -1.7% | - | - | |
| Dec 4, 2024 | VRNO Verano Holdings Corp. | Miles Aaron Nathaniel | Chief Investment Officer | Sell | 6,842 | $1.38 | $9,428.28 | -2.0% | - | - |